These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14706904)

  • 1. [The cost of screening for breast and cervical cancer in France].
    Watt S
    Bull Cancer; 2003 Nov; 90(11):997-1004. PubMed ID: 14706904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cost of breast cancer screening in France].
    Wait S; Schaffer P; Séradour B; Guldenfels C; Gairard B; Morin F; Piana L
    J Radiol; 2000 Jul; 81(7):799-806. PubMed ID: 10915994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of screening for cancerous and precancerous lesions of the cervix.
    Méréa E; Le Galès C; Cochand-Priollet B; Cartier I; de Crémoux P; Vacher-Lavenu MC; Vielh P; Coste J
    Diagn Cytopathol; 2002 Oct; 27(4):251-7. PubMed ID: 12357505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effective policies for cervical cancer screening. An international review.
    Fahs MC; Plichta SB; Mandelblatt JS
    Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.
    Campos NG; Tsu V; Jeronimo J; Mvundura M; Lee K; Kim JJ
    Int J Cancer; 2017 Mar; 140(6):1293-1305. PubMed ID: 27925175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cervical cancer: which common technique is the most cost-effective choice?
    Wiwanitkit V
    Asian Pac J Cancer Prev; 2009; 10(3):531-2. PubMed ID: 19640204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer.
    Moriña D; Martí JI; Puig P; Diaz M
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):211. PubMed ID: 32887589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To what extent is women's economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010.
    Menvielle G; Richard JB; Ringa V; Dray-Spira R; Beck F
    Cancer Causes Control; 2014 Aug; 25(8):977-83. PubMed ID: 24842393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.
    Vanni T; Luz PM; Grinsztejn B; Veloso VG; Foss A; Mesa-Frias M; Legood R
    Int J Cancer; 2012 Jul; 131(2):E96-104. PubMed ID: 21964797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
    Trogdon JG; Ekwueme DU; Subramanian S; Miller JW; Wong FL
    Cancer Causes Control; 2019 Aug; 30(8):813-818. PubMed ID: 31187351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
    Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
    Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance of harms, benefits, and costs of screening for cervical cancer in older women: the case for continued screening.
    Mandelblatt J; Lawrence W; Yi B; King J
    Arch Intern Med; 2004 Feb; 164(3):245-7; discussion 247-8. PubMed ID: 14769618
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
    Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
    Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness of a cervical cancer screening programme in the Algarve region, Portugal].
    Novoa Vázquez RM
    Rev Esp Salud Publica; 2004; 78(3):341-53. PubMed ID: 15293955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women (Connected2Care): study protocol for a randomised controlled trial.
    Linde DS; Andersen MS; Mwaiselage JD; Manongi R; Kjaer SK; Rasch V
    Trials; 2017 Nov; 18(1):555. PubMed ID: 29162148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.